4-hydroxyclomiphene has been researched along with Breast Cancer in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koga, M; Sutherland, RL | 2 |
Koga, M; Musgrove, EA; Sutherland, RL | 1 |
Musgrove, EA; Sutherland, RL; Wakeling, AE | 1 |
Hall, RE; Ruenitz, PC; Sutherland, RL; Watts, CK | 1 |
Ruenitz, PC; Sutherland, RL; Watts, CK | 1 |
6 other study(ies) available for 4-hydroxyclomiphene and Breast Cancer
Article | Year |
---|---|
Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antioestrogen to inhibit T-47D human breast cancer cell proliferation.
Topics: Breast Neoplasms; Calcitriol; Cell Division; Cell Line; Clomiphene; Drug Synergism; Estradiol; Estrogen Antagonists; Female; Humans; Kinetics; Pyrrolidines; Receptors, Calcitriol; Receptors, Estradiol; Receptors, Steroid; Tamoxifen; Thiophenes; Tretinoin | 1991 |
Modulation of the growth-inhibitory effects of progestins and the antiestrogen hydroxyclomiphene on human breast cancer cells by epidermal growth factor and insulin.
Topics: Breast Neoplasms; Cell Division; Clomiphene; Epidermal Growth Factor; Estrogen Antagonists; Female; Growth Inhibitors; Humans; Insulin; Pregnenediones; Progestins; Tumor Cells, Cultured | 1989 |
Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle.
Topics: Breast Neoplasms; Calmodulin; Cell Cycle; Clomiphene; DNA; Estradiol; Estrogen Antagonists; Female; Humans; Imidazoles; Polyunsaturated Alkamides; Tumor Cells, Cultured | 1989 |
Epidermal growth factor partially reverses the inhibitory effects of antiestrogens on T 47D human breast cancer cell growth.
Topics: Breast Neoplasms; Cell Division; Cell Line; Clomiphene; Epidermal Growth Factor; Estrogen Antagonists; Humans; Pyrrolidines; Tamoxifen; Thiophenes | 1987 |
Mechanisms of growth inhibition by nonsteroidal antioestrogens in human breast cancer cells.
Topics: Breast Neoplasms; Calmodulin; Cell Division; Clomiphene; Estradiol; Female; Humans; Interphase; Kinetics; Phenothiazines; Receptors, Drug; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 1987 |
Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytriphenylethylenes with high affinity for the estrogen receptor.
Topics: Binding, Competitive; Breast Neoplasms; Cell Division; Cell Line; Clomiphene; Estradiol; Estrogen Antagonists; Humans; Receptors, Estrogen; Stilbenes; Tamoxifen | 1986 |